Financials

  • Market Capitalization 22.71 B
  • Employee 1 400
  • Founded 1996
  • CEO N/A
  • Website www.unither.com
  • Headquarter Delaware, United States
  • FIGI BBG000BV4XJ1
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
17.49
Price to sales ratio
7.33

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
536
INSM
Insmed Incorporated - Common Stock
109.07 USD-5.66%-2.98%+13.76%-32.69%23.64 B USD
555
INCY
Incyte Corporation - Common Stock
114.23 USD-2.12%-2.81%+5.50%+66.10%22.82 B USD
576
BNTX
BioNTech SE - American Depositary Shares
90.07 USD-1.55%-4.60%+1.09%-18.98%21.61 B USD
659
ASND
Ascendis Pharma A/S - American Depositary Shares
264.28 USD-2.28%-2.18%+18.82%+28.87%16.38 B USD

Frequently asked questions about United Therapeutics Corporation - Common Stock

What is the United Therapeutics Corporation - Common Stock stock price today?

The current price of United Therapeutics Corporation - Common Stock (UTHR) is 535.12. Over the past 24 hours, the stock has changed by -2.18%. Follow the UTHR chart for real-time price dynamics.

What is the stock ticker of United Therapeutics Corporation - Common Stock?

United Therapeutics Corporation - Common Stock trades under the ticker UTHR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is United Therapeutics Corporation - Common Stock stock going up?

UTHR has changed by -2.55% over the last week, -2.28% over the last month, and +81.88% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was United Therapeutics Corporation - Common Stock net income for the last quarter?

United Therapeutics Corporation - Common Stock reported net income of 274.9 M for the last quarter. The previous quarter showed 364.3 M, which means net income changed by -24.54%.

How many employees does United Therapeutics Corporation - Common Stock have?

As of the latest available data, United Therapeutics Corporation - Common Stock has 1 400 employees. Workforce size can provide additional context about the company's scale and operations.

What is United Therapeutics Corporation - Common Stock EBITDA?

United Therapeutics Corporation - Common Stock EBITDA is 348.4 M, and its EBITDA margin is 44.58%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy United Therapeutics Corporation - Common Stock stock?

You can buy United Therapeutics Corporation - Common Stock (UTHR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in United Therapeutics Corporation - Common Stock stock?

Investing in United Therapeutics Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the UTHR chart and related analysis on metatrader.com as part of your research.

United Therapeutics Corporation - Common Stock

United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.

News